Cytomegalovirus infection in pregnant women - threats, diagnosis and treatment
DOI:
https://doi.org/10.12775/JEHS.2022.12.12.029Keywords
cytomegalovirus, congenital cytomegaly infection, pregnancy, diagnostics, treatmentAbstract
Cytomegalovirus is one of the most widespread DNA viruses, with 90% of women of childbearing age in Poland infected with it. Infection poses a risk to the mother as well as the fetus, as the virus can cross the placenta and damage the fetus. The purpose of this paper is to review scientific publications from 2017-2022, which describe the course of cytomegalovirus infection in pregnant women, the risks to the mother and fetus associated with the infection, methods of diagnosing the infection in the pregnant woman and the fetus, as well as treatment of cytomegalovirus infection and directions for vaccine research.
The most common complications of congenital cytomegalovirus infection include hearing loss, mental developmental delays and miscarriage. The infection can be detected in the pregnant woman by immunological testing, while polymerase chain reaction is used in the fetus and newborn. Early detection of infection in a pregnant woman allows the implementation of treatment which includes ganciclovir, valganciclovir, acyclovir and valacyclovir. A vaccine against cytomegalovirus has not been developed. Particularly important in the prevention of infection is to conduct educational activities regarding the routes of transmission of the virus and the consequences of congenital infection for the fetus.
Cytomegalovirus infections among pregnant women. It is important to monitor fetal development and possibly diagnose for congenital CMV infection in case of abnormalities, and the best diagnostic method is polymerase chain reaction testing. For the treatment of congenital CMV infection, acyclovir and valacyclovir are preferred, and therapy should be implemented for specific indications. Attention should be paid to educating women about infections caused by cytomegalovirus.
References
Britt WJ, Pass RF, Stagno S. Pediatric cytomegalovirus infection. Transpl. Proc. 1991;23(3):113–115.
National Center for Immunization and Respiratory Diseases, Division of Viral Diseases. Cytomegalovirus (CMV) and Congenital CMV Infection. https://www.cdc.gov/cmv/index.html (dostęp: 2022.11.06).
Woźniakowska-Gęsicka T, Wróblewska W, Wiśniewska-Ligier M. Rola wirusa cytomegalii w patologii wieku rozwojowego. Pediatr. Pol. 2006;81:674–678.
Xu WF, Yuan TM. A review on the prevention and treatment of congenital cytomegalovirus infection in mothers and infants. Zhongguo Dang Dai Er Ke Za Zhi. 2018;20(10):870-875. doi: 10.7499/j.issn.1008-8830.2018.10.018.
Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034. doi: 10.1002/rmv.2034.
Polz-Dacewicz M. Wirus cytomegalii – epidemiologia, diagnostyka, leczenie i zapobieganie. Forum Zakażeń. 2013;4(1):35-41.
Barlinn R, Dudman SG, Trogstad L, Gibory M, Muller F, Magnus P, Rollag H. Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study. APMIS. 2018;126(12):899-906. doi: 10.1111/apm.12899.
Tastad KJ, Schleiss MR, Lammert SM, Basta NE. Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening. PLoS One. 2019;14(8):e0221725. doi: 10.1371/journal.pone.0221725.
Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutré S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177-e188. doi: 10.1016/S1473-3099(17)30143-3.
Prince HE, Lapé-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol. 2014;21(10):1377-84. doi: 10.1128/CVI.00487-14.
Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol. 2018;42(3):149-154.
doi: 10.1053/j.semperi.2018.02.002.
Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB; National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364(22):2111-8. doi: 10.1056/NEJMoa1006561.
Lisowska-Mikołajków D, Mikołajków A, Reczuch J, Królak-Olejnik B. Congenital Cytomegalovirus infection - still a relevant problem (based on own experience and literature). Dev Period Med. 2018;22(1):49-57. doi: 10.34763/devperiodmed.20182201.4957.
Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009;46 Suppl 4:S6-10.
doi: 10.1016/j.jcv.2009.09.002.
Williams EJ, Embleton ND, Clark JE, Bythell M, Ward Platt MP, Berrington JE. Viral infections: contributions to late fetal death, stillbirth, and infant death. J Pediatr. 2013;163(2):424-8. doi: 10.1016/j.jpeds.2013.02.004.
Leruez-Ville M, Foulon I, Pass R, Ville Y. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol. 2020;223(3):330-349. doi: 10.1016/j.ajog.2020.02.018.
Duszczyk E. Cytomegalia. https://www.mp.pl/pacjent/choroby-zakazne/choroby/zakazenia-wirusowe/157123,cytomegalia
(dostęp: 2022.11.07).
Enders G, Daiminger A, Bäder U, Exler S, Enders M. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol. 2011;52(3):244-6. doi: 10.1016/j.jcv.2011.07.005.
Uchida A, Tanimura K, Morizane M, Fujioka K, Morioka I, Oohashi M, Minematsu T, Yamada H. Clinical Factors Associated With Congenital Cytomegalovirus Infection: A Cohort Study of Pregnant Women and Newborns. Clin Infect Dis. 2020;71(11):2833-2839.
doi: 10.1093/cid/ciz1156.
Lazzarotto T, Blázquez-Gamero D, Delforge ML, Foulon I, Luck S, Modrow S, Leruez-Ville M. Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts. Front Pediatr. 2020;8:13.
doi: 10.3389/fped.2020.00013.
Tsuge M, Hida AI, Minematsu T, Honda N, Oshiro Y, Yokoyama M, Kondo Y. Prospective Cohort Study of Congenital Cytomegalovirus Infection during Pregnancy with Fetal Growth Restriction: Serologic Analysis and Placental Pathology. J Pediatr. 2019;206:42-48.e2.
doi: 10.1016/j.jpeds.2018.10.003.
Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 2008;198(4):380.e1-7. doi: 10.1016/j.ajog.2007.09.052.
Leruez-Ville M, Magny JF, Couderc S, Pichon C, Parodi M, Bussières L, Guilleminot T, Ghout I, Ville Y. Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva. Clin Infect Dis. 2017;65(3):398-404. doi: 10.1093/cid/cix337.
Luck SE, Wieringa JW, Blázquez-Gamero D, Henneke P, Schuster K, Butler K, Capretti MG, Cilleruelo MJ, Curtis N, Garofoli F, Heath P, Iosifidis E, Klein N, Lombardi G, Lyall H, Nieminen T, Pajkrt D, Papaevangelou V, Posfay-Barbe K, Puhakka L, Roilides E, Rojo P, Saavedra-Lozano J, Shah T, Sharland M, Saxen H, Vossen ACTM; ESPID Congenital CMV Group Meeting, Leipzig 2015. Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J. 2017;36(12):1205-1213.
doi: 10.1097/INF.0000000000001763.
Wutzler P, Thust R. Genetic risks of antiviral nucleoside analogues--a survey. Antiviral Res. 2001;49(2):55-74.
doi: 10.1016/s0166-3542(00)00139-x.
Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG. 2007;114(9):1113-21. doi: 10.1111/j.1471-0528.2007.01308.x.
Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G, Hamprecht K. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration. Ultrasound Obstet Gynecol. 2019;53(3):383-389. doi: 10.1002/uog.19164.
De la Calle M, Baquero-Artigao F, Rodríguez-Molino P, Cabanes M, Cabrera M, Antolin E, Mellado MJ, Bartha JL. Combined treatment with immunoglobulin and valaciclovir in pregnant women with cytomegalovirus infection and high risk of symptomatic fetal disease. J Matern Fetal Neonatal Med. 2022;35(16):3196-3200. doi: 10.1080/14767058.2020.1815188.
Lazzaro A, Vo ML, Zeltzer J, Rawlinson W, Nassar N, Daly K, Lainchbury A, Shand A. Knowledge of congenital cytomegalovirus (CMV) in pregnant women in Australia is low, and improved with education. Aust N Z J Obstet Gynaecol. 2019;59(6):843-849.
doi: 10.1111/ajo.12978.
Reichman O, Miskin I, Sharoni L, Eldar-Geva T, Goldberg D, Tsafrir A, Gal M. Preconception screening for cytomegalovirus: an effective preventive approach. Biomed Res Int. 2014;2014:135416. doi: 10.1155/2014/135416.
Gerna G, Lilleri D. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine. New Microbiol. 2019;42(1):1-20.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Arkadiusz Grunwald, Kinga Brzuszkiewicz, Katarzyna Nowak, Małgorzata Satora, Jakub Klas, Gracjan Rudziński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 483
Number of citations: 0